These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Yatsuga S; Suomalainen A Hum Mol Genet; 2012 Feb; 21(3):526-35. PubMed ID: 22012983 [TBL] [Abstract][Full Text] [Related]
5. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy. Kimoloi S Pharmacol Res; 2018 Dec; 138():37-42. PubMed ID: 30267763 [TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway. Ji K; Zheng J; Lv J; Xu J; Ji X; Luo YB; Li W; Zhao Y; Yan C Free Radic Biol Med; 2015 Jul; 84():161-170. PubMed ID: 25843656 [TBL] [Abstract][Full Text] [Related]
8. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Graham BH; Waymire KG; Cottrell B; Trounce IA; MacGregor GR; Wallace DC Nat Genet; 1997 Jul; 16(3):226-34. PubMed ID: 9207786 [TBL] [Abstract][Full Text] [Related]
9. GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH. Kim KH; Lee MS Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129834. PubMed ID: 33358864 [TBL] [Abstract][Full Text] [Related]
10. Secondary mitochondrial dysfunction across the spectrum of hereditary and acquired muscle disorders. Mak G; Tarnopolsky M; Lu JQ Mitochondrion; 2024 Sep; 78():101945. PubMed ID: 39134108 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics. O'Gorman E; Piendl T; Müller M; Brdiczka D; Wallimann T Mol Cell Biochem; 1997 Sep; 174(1-2):283-9. PubMed ID: 9309701 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384 [TBL] [Abstract][Full Text] [Related]
16. Effect of mitochondrial stress on systemic metabolism. Lee MS Ann N Y Acad Sci; 2015 Sep; 1350():61-5. PubMed ID: 26100439 [TBL] [Abstract][Full Text] [Related]
17. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Larsson NG; Oldfors A; Holme E; Clayton DA Biochem Biophys Res Commun; 1994 May; 200(3):1374-81. PubMed ID: 8185589 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation. Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564 [TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Keipert S; Ost M; Johann K; Imber F; Jastroch M; van Schothorst EM; Keijer J; Klaus S Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E469-82. PubMed ID: 24347058 [TBL] [Abstract][Full Text] [Related]
20. mTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4. Park Y; Reyna-Neyra A; Philippe L; Thoreen CC Cell Rep; 2017 May; 19(6):1083-1090. PubMed ID: 28494858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]